Nécessite une authentification
Use of eVAR and anti-eVAR as interim terms
| 28 déc. 2022
À propos de cet article
Publié en ligne: 28 déc. 2022
Pages: 139 - 140
DOI: https://doi.org/10.21307/immunohematology-2022-058
© 2022 Sandra Nance, published by Sciendo
Sandra Nance
Director Immunohematology Reference LaboratoryPhiladelphia, PA, United States